Product Program year 2025 Source: CMS Open Payments

Evis Exera III Duodenovideoscope

Device Gastroenterology

PDI 04953170405563

Open in the dashboard

General payments

$875,301

623 payments

Research payments

$1,337,290

32 payments

Through program year 2025, $875,301 in general payments and $1,337,290 in research payments were reported against Evis Exera III Duodenovideoscope (Gastroenterology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

9 rows
Year Kind Amount Payments
2025 General $256,054 172
2024 General $59,911 127
2024 Research $148,000 4
2023 General $231,384 141
2023 Research $1,022,750 18
2022 General $172,401 90
2022 Research $73,500 8
2021 General $155,550 93
2021 Research $93,040 2

Breakdown

Who paid General payments · program years 2021–2025
  1. Olympus America Inc. $571,836 245 payments
  2. Olympus Corporation of the Americas $194,026 125 payments
  3. Olympus Medical Systems Corporation $68,614 69 payments
  4. Olympus Latin America, Inc. $21,851 21 payments
  5. Olympus Corporation $18,972 163 payments
Top recipients General payments · program year 2025
  1. Regions Hospital Teaching hospital · MN $109,629 43% · 1 payment
  2. Nationwide Childrens Hospital Teaching hospital · OH $24,000 9% · 6 payments
  3. Adventhealth Orlando Teaching hospital · FL $8,031 3% · 3 payments
  4. Seattle Childrens Hospital Teaching hospital · WA $8,000 3% · 2 payments
  5. Univ Of Mi Hospitals & Hlth Ctrs Teaching hospital · MI $4,000 2% · 1 payment

The top 5 of 77 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Gastroenterology Internal Medicine $65,565 87% · 53 practitioners
  2. Pediatric Gastroenterology Pediatrics $8,379 11% · 4 practitioners
  3. Internal Medicine $1,464 2% · 2 practitioners
  4. Nurse Practitioner $23 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Minnesota $112,805 44% · 3 recipients
  2. California $33,934 13% · 20 recipients
  3. Ohio $24,000 9% · 1 recipient
  4. Florida $13,071 5% · 6 recipients
  5. Illinois $12,507 5% · 15 recipients

The top 5 of 18 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

623 general · 32 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record